CCCNC(=O)C1(CC2CC(c3ccccc3)=NO2)CCN(C(=O)c2cc(OCC)c(OCC)c(OCC)c2)CC1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?